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Background: Hemangioblastoma (HB) is a benign, slow-growing, 
highly vascular tumour of not well defined histological origin. These 
tumors make up about 1 to 2 percent of all intracranial neoplasms and 
occur primarily in the posterior fossa. Hemangioblastomas can occur 
sporadically but in about 20% to 30% cases, it is associated with von 
Hippel-Lindau (VHL) disease. 9 cases of hemangioblastomas were 
examined with haematoxylin & eosin (H&E), reticulin stain and 
immunohistochemistry where ever needed. Their ages ranged from 12 
years to 60 years. All of them were as presented as cystic nodules. The 
main histological differential diagnosis of Haemaniioblastoma is 
metastatic clear cell carcinoma. Additionally, because of the cystic 
mural features, pilocytic astrocytomas of the cerebellum must be 
separated from haemangioblastomas. 
Materials and Methods: The data for the present study was collected 
from the record section of the department of Pathology of our hospital. 
Histomorphological and immunohistochemical evaluation of all the 
cases of hemangioblastomas was done. 
 Results: In the present study we had 9 cases with 2 of them being 
recurrent in nature. Age range was 12 to 60 yrs (median: 32 yrs) with 
Male to Female ratio of 2: 1 (M-6; F-3). Cerebellum was commonest 
location followed by brain stem.  
Conclusion: Hemangioblastomas can occur in throughout the 
neuroaxis. Cerebellum is the commonest site of occurrence for 
Haemangioblastoms. 
 
                 Copy Right, IJAR, 2019,. All rights reserved. 
…………………………………………………………………………………………………….... 
Introduction:- 
The term ‘hemangioblastoma’ (HB) was introduced by Cushing and Bailey in 1928, occurs in the central nervous 
system (CNS) and represents 1.5-2.5% of all the intracranial neoplasms.[1,2] As per the current WHO CNS tumors 
classification, it is a grade I tumor. They are usually infratentorial; cerebellum around the fourth ventricle is the 
commonest site of occurrence and supratentorial location is lesser common. Other very rare extracerebellar sites of 
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occurrence include spinal cord (more commonly medulla, spinal roots including cauda equina), brain stem, optic 
nerve, retina and craniospinal meninges.[3-7] HBs may be associated with von Hippel-Lindau (VHL) disease, which 
is an autosomal dominant disease. Histologically, HBs are characterized by rich vascularity, typically consisting of 
capillary-sized blood vessels separated by intervascular stromal cells (SCs). These tumors are still regarded as 
‘neoplasms of uncertain histogenesis. Though the histological origin of the SCs is not yet fully characterized but has 
been shown to be the neoplastic cells. Moreover, it has been now shown that tumorigenesis of HBs depends on 
mutational inactivation of VHL tumor suppressor gene.[8] Few studies even suggested VHL gene regulation of 
tumor angiogenesis by negative regulation of vascular endothelial growth factor (VEGF) expression.[9-11]. 
 
Material and Methods:- 
The data for the present study was collected from the record section of the department of Pathology of our hospital. 
Two year period from January 2017 to January 2019 was taken for the present study. A total no. of 9 cases were 
evaluated. Information about age, gender, tumor location and tumor size were determined for each case of 
haemangioblastoma. 
 
Results:- 
In the present study a total no. of 9 cases were evaluated. The age of the patients ranged from 12 to 60 yrs, and a 
mean age was 36yrs. The male to female ratio was 2:1. The patients presented with headache, neck pain and 
vomiting. The cerebellum being the most common site (7cases /77.78%), and it was followed by the brain stem 
(2cases/22.22%). Recurrent hemangiomablastomas (figure 1) were seen in 2 cases /22.22%). Radiologically 
haemangioblastomas show solid (mural nodule) –cystic component. (Fig 1) In the histopathological examination, the 
tumor sections showed large and vacuolated stromal cells and numerous arborizing capillary-size blood vessels (fig 
2). Vimentin was strongly positive both stromal cells and blood vessels in all tumors. CD34 immunostaining 
highlighted the arborizing and complex vascular network, whereas the tumor stromal cells were negative (fig 3). 
Stromal cells showed positivity for S100 (fig 4). 
 
 
Figure 1:-This radiographic image of a male patient shows Solid cystic changes in a recurrent haemangioblastoma. 
 
 
Fig 2:-Photomicrograph of the tumor sections shows large and vacuolated stromal cells and numerous arborizing 
capillary-size blood vessels.( H&E,100X). 
ISSN: 2320-5407                                                                                      Int. J. Adv. Res. 7(4), 903-907 
905 
 
 
 
Fig 3:-Photomicrograph shows blood vessels of hemangioblastoma positive for CD34. (IHC 100X) 
 
 
Fig 4:-Photomicrograph shows stromal cells of the tumor positive for S100 (IHC 400X) 
 
Discussion:- 
Capillary hemangioblastoma is a slowly growing tumor which usually has cystic features morphologically (12). On 
computerized tomography (CT), it is recognized as a contrast-enhancing nodule because of its cystic features (13, 
14,15). The symptoms are associated with the progressively growing cystic component of the tumor. In some cases, 
as a result of the erythropoetin secretion from the vascular endothelial cells of the tumor, polycythemia becomes 
apparent (12-14). Macroscopically, hemangioblastoma is a well-circumscribed tumor which has both solid and 
cystic components (14, 16). The solid component, so called the mural nodule shows contrast enhancement on CT 
and prominent vascular features on angiography. Macroscopically, the tumor has a bright yellow color as a result of 
its lipid content (13-15). The histological features are rather original consisting of 2 components. These components 
are the capillary network lined by hyperplastic endothelial cells and the stromal cells which have pleomorphic or 
lobulated nuclei and lipid containing abundant, pale cytoplasms (13-15, 17). Mitoses are usually inapparent (13, 14) 
the origin of the stromal cells is controversial. The expression of growth factors and growth factor receptors have 
been studied by Böhling et al. (18), and it has been found that the stromal cells express abundant epidermal growth 
factor receptor (EGFR) and some platelet-derived growth factor receptor-alpha (PDGF-alpha). It was concluded that 
the expression of highly angiogenic growth factors and their receptors might contribute to the rich vascularity of the 
tumor. The stromal cells reveal immunoreactivity for cytokeratin, vimentin, neuron-specific enolase (NSE), S-100 
protein, glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA) and actin, but are negative with 
F-VIII/von Willebrand’s factor (13-15,19). On the other hand, the relation between angiogenesis and tissue 
expression of vascular endothelial growth factor (VEGF) has been studied by Vaquero J et al. (20) and it has been 
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found that the number of intratumoral microvessels, identified by the endothelial marker CD 34, does not correlate 
with the degree of VEGF expression. This finding suggests that endothelial growth factors other than VEGF may 
regulate tumor angiogenesis in these neoplasms. Especially the immunoreactivity with vimentin, GFAP, EMA and 
cytokeratin is almost identical to the reactivity pattern of meningotheliomatous TUNA et al. 173 meningioma and so 
the possibility of the stromal cells of hemangioblastoma to derive from the arachnoid cells of meningotheliomatous 
meningiomas by cellular degeneration has been considered (21). Although there are many different views about the 
histogenesis of the stromal cells, its exact origin is still not clear. In both of our cases, hematoxylen-eosin stained 
sections were sufficient for the diagnosis. The immunohistochemical stains were applied to support the diagnosis. In 
the differential diagnosis of capillary hemangioblastoma, metastatic renal cell carcinoma must be considered. Renal 
cell carcinoma shows necrosis, mitoses and cytokeratin, vimentin and EMA immunoreactivity, which are important 
clues in distinction (13-15). It is also suggested that the AgNOR method is a useful adjunct in achieving the 
differential diagnosis of hemangioblastoma and renal cell carcinoma in the nervous system (22). Anaplastic 
astrocytoma and meningioma also show similarity to the tumor (23). In the study, in which cytologic features of 
hemangioblastoma are compared with meningioma, anaplastic astrocytoma and renal cell carcinoma intraoperative 
smears were evaluated and concluded that smears of hemangioblastomas are cellular and cohesive, the cytoplasmic 
borders are indistinct and the nuclei are hyperchromatic and mildly pleomorphic. Smears of meningiomas, 
anaplastic astrocytomas and renal cell carcinomas are more discohesive than those of hemangioblastomas. The cells 
of renal cell carcinoma show distinct cellular borders while in astrocytoma there is prominent cytoplasmic 
fibrillarity (23). Another lesion which must be considered in the differential diagnosis is angioglioma (14, 24). In 
angioglioma the neoplastic astroglial cells are scattered among the vascular structures and usually the glial 
component is prominent (24). Capillary hemangioblastomas may be multiple (13, 25). As a conclusion, capillary 
hemangioblastomas are biologically slowly growing lesions which have cystic and solid (mural) features 
morphologically. The symptoms are associated with the progressively growing cystic component of the tumor. 
Hemangioblastomas show very good prognosis with sufficient surgical excision, but with insufficient excisions 
recurrences are inevitable as was seen in two cases of our study. 
 
Conclusion:- 
Hemangioblastomas can occur in throughout the neuroaxis. Cerebellum is the commonest site of occurrence for 
Haemangioblastoms. 
 
Conflict of interest:  
None 
 
Funding: 
None 
 
Refrences:- 
1. Cushing H, Bailey P. Tumours arising from the blood vessels of the brain. Angiomatous malformations and 
Haemangioblastomas. London: Bailliere. Tindall and Cox; 1928.  
2. Aldape KD, Plate KH, Vortmeyer AO, Zagzag D, Neumann HPH. Haemangioblastoma. In: Louis DN, Ohgaki 
H, Wiestler OD, Cavenee WK, editors. WHO Classification of tumours of the Central Nervous System. 4th Ed. 
Lyon, France: IARC; 2007. p.184-6.  
3. Kepes JJ, Slowik F. Arvid Lindau’s cerebellar hemangioblastoma 70 years later. Some pediatric aspects. Ann N 
Y Acad Sci 1997;824:112-3. 
4. Aickalin MF, Oner U, Tel N. Supratentorial haemangioblastoma: A case report and review of the literature. 
Arch Pathol Lab Med 2003;12:e382-4.  
5. Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the 
central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 
1989;70:24-30.  
6. Richmond BK, Schmidt JH. Congenital cystic supratentorial hemangioblastoma. Case report. J Neurosurg 
1995;82:113-5. 
7. Rubio A, Meyers SP, Powers JM, Nelson CN, de Papp EW. Hemangioblastoma of the optic nerve. Hum Pathol 
1994;25:1249-51. 
ISSN: 2320-5407                                                                                      Int. J. Adv. Res. 7(4), 903-907 
907 
 
8. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, et al. von Hippel-Lindau 
gene deletion detected in the stromal cell component of a cerebellar haemangioblastoma associated with von 
Hippel-Lindau disease. Hum Pathol 1997;28:540-3. 
9. Hussein MR. Central nervous system capillary haemangioblastoma: The pathologist’s viewpoint. Int J Exp 
Pathol 2007;88:311-24. 
10. Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ. The HIF pathway: Implications for patterns of 
gene expression in cancer. Novatis Found Symp 2001;240:212-25. 
11. Hatva E, Böhling T, Jääskeläinen J, Persico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in 
capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996;148:763-75. 
12. 12.McKeever PE. Central Nervous System. In: Sternberg SS, Antonioli DA, Carter D, et al. editors. Diagnostic 
Surgical Pathology. 3rd ed. Philadelphia: Lippincott William&Wilkins, 1999; 411-60. 
13. Parici EJ, Mena H. Nonglial Tumours. In: Nelson JS, Parisi JE, Schochet SJr, editors. Principles and Practice of 
Neuropathology. St. Louis: Mosby, 1993; 203-66.  
14. Namiki H, Hardman MJ, Yang H. The Central Nervous System. In: Silverberg SG, Delellis RA, Frable WJ, 
editors. Principles and Practice of 174 CEREBELLAR HEMANGIOBLASTOMA Surgical Pathology and 
Cytopathology. 3rd ed. Churchill and Livingstone, 1997; 2905-3036.  
15. Rosenbium MK. Neuromuscular System: Central Nervous System. In: Rosai J, editor. Ackerman’s Surgical 
Pathology. 8th ed. New York: Mosby, 1996;2227-65.   
16. Giannini C, Scheithauer BW, Hellbuch LC. Peripheral nerve hemangioblastoma. Mod Pathol 1998;11:999-
1004. 
17. Böhling T, Maenpaa A, Timonen T, et al. Different expression of adhesion molecules on stromal cells and 
endothelial cells of capillary hemangioblastoma. Acta Neuropathol 1996;92:461-6. 
18. Böhling T, Hatva E, Kujala M. Expression of growth factors and growth factor receptors in capillary 
hemangioblastoma. J Neuropathol Exp Neurol 1996; 55(5): 522-7.  
19. McComb RD, Jones TR, Pizzo SV, et al. Localisation of factor VIII/von Willebrand factor and glial fibrillary 
acidic protein in the hemangioblastoma: implications for stromal cell histogenesis. Acta Neuropathol 
1982;56:207-13. 
20. Vaquero J, Zurita M, Coca S. Expression of vascular endothelial growth factor in cerebellar hemangioblastomas 
does not correlate with tumor angiogenesis. Cancer Lett 1998;132:213-7.  
21. Mizuno J, Iwata K, Takei Y. Immunohistochemical study of hemangioblastoma with special reference to its 
cytogenesis. Neurol Med Chir 1993;33:420-4.  
22. Crocker J, Carey MP, Allcock R. Hemangioblastoma and renal clear cell carcinoma distinguished by means of 
the AgNOR method. Am J Clin Pathol 1990;93:555-7.  
23. Commins DL, Hinton DR. Cytologic features of hemangioblastoma: comparison with meningioma, anaplastic 
astrocytoma and renal cell carcinoma. Acta Cytol 1998;42:1104-10.  
24. Bonnin JM, Pena CE, Rubinstein LJ. Mixed capillary hemangioblastoma and glioma. A redefinition of the 
"angioglioma". J Neuropathol Exp Neurol 1983;504-16.  
25. Gumprecht H, Lumenta CB. Multifocal hemangioblastoma in a young woman with von Hippel-Lindau 
syndrome. Neurochir 1998;59:181-4. 
